Q4 2022 Holdings
Filed 2023-02-14 | 94 holdings | $196.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $20.2M | 1,355,372 | 10.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $11.1M | 2,870,000 | 5.7% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $10.1M | 385,000 | 5.1% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $9.3M | 1,132,000 | 4.7% |
| Pepperlime Health Acqustn Co | CLASS A ORD SHS | G70021103 | $7.5M | 735,000 | 3.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $6.9M | 125,000 | 3.5% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.4M | 1,025,000 | 3.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.6M | 215,000 | 2.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.3M | 100,000 | 2.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.2M | 140,000 | 2.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $5.0M | 170,000 | 2.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $4.6M | 150,000 | 2.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $4.4M | 160,000 | 2.2% |
| Karuna Therapeutics Inc | COM | 48576A100 | $4.3M | 22,000 | 2.2% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $4.1M | 6,246,291 | 2.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.1M | 190,000 | 2.1% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $4.0M | 90,000 | 2.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $4.0M | 91,000 | 2.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $3.9M | 620,000 | 2.0% |
| Outlook Therapeutics Inc(ONSGBP) | COM NEW | 69012T206 | $3.6M | 3,327,404 | 1.8% |
| Resmed Inc(RMD) | COM | 761152107 | $3.5M | 17,000 | 1.8% |
| Akoya Biosciences Inc | COM | 00974H104 | $3.2M | 330,000 | 1.6% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $3.1M | 224,800 | 1.6% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $3.1M | 212,000 | 1.6% |
| Koru Medical Systems Inc(KRMD) | COM | 759910102 | $3.1M | 855,000 | 1.6% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $3.0M | 76,000 | 1.5% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $3.0M | 365,000 | 1.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.8M | 200,000 | 1.4% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $2.7M | 450,000 | 1.4% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $2.7M | 195,000 | 1.3% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $2.6M | 285,000 | 1.3% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $2.1M | 195,960 | 1.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.1M | 17,500 | 1.1% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $2.1M | 90,000 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.1M | 43,000 | 1.0% |
| TG Venture Acquisition Corp | UNIT 08/15/2028 | 87251T208 | $2.0M | 200,000 | 1.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.9M | 100,000 | 1.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.9M | 50,000 | 1.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $1.8M | 3,103,635 | 0.9% |
| Ault Disruptive Techs Corp | COM | 05150A104 | $1.5M | 150,000 | 0.8% |
| TG Therapeutics IncCall | CALL | 88322Q908 | $1.2M | 100,000 | 0.6% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.1M | 315,070 | 0.6% |
| Western Acqstn Ventures Corp | UNIT 09/01/2026 | 95758L206 | $1.1M | 100,000 | 0.6% |
| Murphy Canyon Acquisition Co | UNIT 01/25/2027 | 626642201 | $1.0M | 100,000 | 0.5% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $1.0M | 100,000 | 0.5% |
| Coliseum Acquisition Corp | CLASS A ORD SHS | G2263T123 | $853.4K | 85,000 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $811.5K | 359,051 | 0.4% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $778.1K | 310,000 | 0.4% |
| Hyrecar Inc(HYREQ) | COM | 44916T107 | $715.8K | 1,688,120 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $712.6K | 70,000 | 0.4% |